U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1209+12T>A AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 12, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000590801.1

Allele description [Variation Report for NM_000492.4(CFTR):c.1209+12T>A]

NM_000492.4(CFTR):c.1209+12T>A

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1209+12T>A
HGVS:
  • NC_000007.14:g.117542120T>A
  • NG_016465.4:g.81337T>A
  • NM_000492.4:c.1209+12T>AMANE SELECT
  • LRG_663t1:c.1209+12T>A
  • LRG_663:g.81337T>A
  • NC_000007.13:g.117182174T>A
  • NM_000492.3:c.1209+12T>A
Links:
dbSNP: rs748021847
NCBI 1000 Genomes Browser:
rs748021847
Molecular consequence:
  • NM_000492.4:c.1209+12T>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000696825Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Dec 12, 2016)
germlineclinical testing

LabCorp Variant Classification Summary - May 2015.docx

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000696825.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The CFTR c.1209+12T>A variant involves the alteration of a non-conserved intronic nucleotide, which 5/5 splice prediction tools predict no significant impact on normal splicing or ESE binding sites, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 6/112318 (1/18719), predominantly in the South Asian cohort, 6/15594 (1/2598), which does not exceed the estimated maximal expected allele frequency for a pathogenic CFTR variant of 1/159. The variant of interest has not been, to our knowledge, reported in affected individuals via publications and/or clinical diagnostic laboratories/databases. Therefore, until additional information becomes available (ie, clinical and functional tudies), the variant of interest has been classified as a "Variant of Uncertain Significance (VUS)."

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024